Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.034x

Based on the latest financial reports, Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥107.21 Million ≈ $15.69 Million USD) by net assets (CN¥3.13 Billion ≈ $458.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shanghai Haoyuan Chemexpress Co. Ltd. A market cap and net worth for the company's overall valuation and market capitalisation.

Shanghai Haoyuan Chemexpress Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Shanghai Haoyuan Chemexpress Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Haoyuan Chemexpress Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Haoyuan Chemexpress Co. Ltd. A ranked by their cash flow conversion efficiency. Explore 688131 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Rev Group Inc
NYSE:REVG
0.185x
North Industries Group Red Arrow Co Ltd
SHE:000519
0.039x
Downer Edi Ltd
AU:DOW
0.105x
Betta Pharmaceuticals Co Ltd
SHE:300558
0.033x
BankUnited Inc
NYSE:BKU
0.043x
Hang Zhou Iron & Steel Co Ltd
SHG:600126
0.124x
Shenzhen Everbest Machinery Indus
SHE:002980
0.001x
CRRC Corporation Limited
F:C2L
-0.034x

Annual Cash Flow Conversion Efficiency for Shanghai Haoyuan Chemexpress Co. Ltd. A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Haoyuan Chemexpress Co. Ltd. A from 2013 to 2025. View Shanghai Haoyuan Chemexpress Co. Ltd. A stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥9.43 Billion
≈ $1.38 Billion
CN¥317.75 Million
≈ $46.50 Million
0.034x -74.37%
2024-12-31 CN¥2.90 Billion
≈ $424.98 Million
CN¥381.96 Million
≈ $55.89 Million
0.132x +633.61%
2023-12-31 CN¥2.53 Billion
≈ $369.67 Million
CN¥-62.27 Million
≈ $-9.11 Million
-0.025x +76.07%
2022-12-31 CN¥2.33 Billion
≈ $341.24 Million
CN¥-240.23 Million
≈ $-35.15 Million
-0.103x -427.11%
2021-12-31 CN¥1.84 Billion
≈ $268.73 Million
CN¥57.83 Million
≈ $8.46 Million
0.031x -85.77%
2020-12-31 CN¥527.81 Million
≈ $77.24 Million
CN¥116.79 Million
≈ $17.09 Million
0.221x +54.98%
2019-12-31 CN¥399.73 Million
≈ $58.49 Million
CN¥57.07 Million
≈ $8.35 Million
0.143x -10.78%
2018-12-31 CN¥177.65 Million
≈ $26.00 Million
CN¥28.43 Million
≈ $4.16 Million
0.160x +72.73%
2017-12-31 CN¥114.74 Million
≈ $16.79 Million
CN¥10.63 Million
≈ $1.56 Million
0.093x +143.20%
2016-12-31 CN¥56.86 Million
≈ $8.32 Million
CN¥-12.19 Million
≈ $-1.78 Million
-0.214x -484.77%
2015-12-31 CN¥32.65 Million
≈ $4.78 Million
CN¥1.82 Million
≈ $266.30K
0.056x +146.55%
2014-12-31 CN¥33.10 Million
≈ $4.84 Million
CN¥-3.96 Million
≈ $-579.94K
-0.120x -197.57%
2013-12-31 CN¥9.70 Million
≈ $1.42 Million
CN¥1.19 Million
≈ $174.12K
0.123x --

About Shanghai Haoyuan Chemexpress Co. Ltd. A

SHG:688131 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.12 Billion
CN¥21.31 Billion CNY
Market Cap Rank
#4834 Global
#808 in China
Share Price
CN¥100.48
Change (1 day)
-1.66%
52-Week Range
CN¥60.36 - CN¥102.18
All Time High
CN¥148.50
About

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.